Skip to content

Application of intelligent continuous infusion pump method for norepinephrine in septic patients

Application of intelligent continuous infusion pump method for norepinephrine in septic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119051
Enrollment
Unknown
Registered
2026-02-14
Start date
2024-08-28
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis and septic shock

Interventions

The control group :Conventional double-pump continuous pumping method (automatic 2-step continuous pumping)
Intervention group: Intelligent medium continuous pumping method (intelligent multi-step 4 or 8-step continuous pumping)

Sponsors

Zhongda Hospital Affiliated to Southeast University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adult (>= 18 years old) sepsis patients admitted to the ICU during the study period (sepsis diagnosis standard is sepsis 3.0); 2. Continuous intravenous infusion of norepinephrine during ICU with a dose greater than 15ug/min;

Exclusion criteria

Exclusion criteria: 1. Severe hemodynamic instability (increase of vasoactive drug dose or MAP 100ug/min); 2. Severe other organ dysfunction is expected to result in short-term death (7 days) or palliative treatment; 3. Late stage solid organ or hematological system tumors with an estimated survival time of<30 days; 4. Pregnancy; 5. Participate in other clinical studies within 30 days; 6. Unsigned informed consent form;

Design outcomes

Primary

MeasureTime frame
Proportion of mean arterial pressure (MAP) decrease >20%;

Secondary

MeasureTime frame
Systolic blood pressure (SBP) level;Diastolic blood pressure (DBP) level;Heart rate (HR) level;Mean arterial pressure (MAP) level;Central venous pressure (CVP) level;Infusion pressure of syringe pump;Number of organ dysfunction (single item >=3 points in SOFA score);Need for mechanical ventilation;Total duration of mechanical ventilation;Use of corticosteroids;Use of neuromuscular blocking agents;ICU length of stay;ICU mortality rate;In-hospital mortality rate;Mechanical ventilation rate;28-day ventilator-free days;28-day ICU-free days;28-day mortality rate;Number of organ dysfunction;

Countries

China

Contacts

Public ContactLi Xiaoqing

Zhongda Hospital Affiliated to Southeast University

22074068@qq.com+86 25 83262550

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026